Oz will give up to run CMS
Dr. Mehmet Oz, the celebrity doctor and former host of “The Dr. Oz Show,” has agreed to give up his position on the board of his family’s medical publishing business if he is confirmed as the head of the Centers for Medicare and Medicaid Services (CMS), according to a report from STAT. Dr. Oz’s nomination has faced scrutiny due to his past promotion of unproven medical treatments and his ties to the supplement industry.
During his confirmation hearing, Dr. Oz stated that he would resign from the board of his family’s company, Oz Media, if confirmed as the head of CMS. However, some senators raised concerns about his ties to the company and the potential for conflicts of interest. Dr. Oz defended his record, stating that he has always prioritized the health and well-being of his patients.
If confirmed, Dr. Oz would be responsible for overseeing the nation’s largest health insurance programs, which provide coverage to millions of Americans. Critics have expressed concerns about his lack of experience in government health policy and his history of promoting controversial medical practices.
Despite the controversy surrounding his nomination, Dr. Oz remains confident that he can make a positive impact as the head of CMS. He has pledged to prioritize access to affordable healthcare and to work towards improving the quality of care for all Americans.
More stories from STAT
That’s it for today! Thanks for reading Morning Rounds. We’ll be back tomorrow with more health and medicine news.Â
Have a great day!
Dr. Mehmet Oz, the controversial pick to run the Centers for Medicare and Medicaid Services (CMS), has made a significant move to address concerns about potential conflicts of interest. Oz’s financial disclosures reveal that he holds stock in UnitedHealth Group and several other healthcare companies, totaling nearly $300 million. In response to these revelations, Oz has pledged to sell all of his stock holdings, resign from advisory roles, and divest from multiple investment funds if confirmed as CMS administrator.
Since his nomination by former President Trump, Oz has maintained a low profile and avoided the backlash that other controversial appointees, such as Robert F. Kennedy Jr., have faced. Despite this, scrutiny of Oz’s financial ties to the healthcare industry has raised questions about his ability to impartially lead CMS.
In other news, the Trump administration’s decision to fire health inspectors at border stations has drawn criticism, with concerns about the impact on public health and safety. Additionally, airlines are facing lawsuits for breaking disabled travelers’ wheelchairs, highlighting ongoing challenges in accessibility for individuals with disabilities.
The medical device lobby is pushing back against proposed FDA cuts, arguing that reduced funding could hinder innovation and patient access to life-saving technologies. Meanwhile, the U.S. government has reversed plans to shut down a free COVID-19 test program, citing the ongoing need for widespread testing.
As lawmakers grapple with budgeting challenges, Republicans are facing what appears to be an impossible task in balancing competing priorities and funding demands. The evolving healthcare landscape continues to present complex challenges for policymakers, healthcare providers, and patients alike.
